Annual Operating Expenses
$67.55 M
+$30.72 M+83.40%
December 31, 2023
Summary
- As of February 7, 2025, SPRY annual total operating expenses is $67.55 million, with the most recent change of +$30.72 million (+83.40%) on December 31, 2023.
- During the last 3 years, SPRY annual operating expenses has risen by +$49.25 million (+269.05%).
- SPRY annual operating expenses is now at all-time high.
Performance
SPRY Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$23.70 M
+$7.86 M+49.65%
September 30, 2024
Summary
- As of February 7, 2025, SPRY quarterly total operating expenses is $23.70 million, with the most recent change of +$7.86 million (+49.65%) on September 30, 2024.
- Over the past year, SPRY quarterly operating expenses has increased by +$7.86 million (+49.65%).
- SPRY quarterly operating expenses is now at all-time high.
Performance
SPRY Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
SPRY Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +83.4% | +49.6% |
| 3 y3 years | +269.1% | +49.6% |
| 5 y5 years | +269.1% | +49.6% |
SPRY Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +170.6% | at high | +248.2% |
| 5 y | 5-year | at high | +269.1% | at high | +248.2% |
| alltime | all time | at high | +269.1% | at high | +248.2% |
ARS Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.70 M(+49.6%) |
| Jun 2024 | - | $15.84 M(+20.1%) |
| Mar 2024 | - | $13.19 M(+29.0%) |
| Dec 2023 | $67.55 M | $10.23 M(-43.1%) |
| Sep 2023 | - | $17.98 M(-12.8%) |
| Jun 2023 | - | $20.61 M(+10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $18.73 M(+21.3%) |
| Dec 2022 | $36.83 M(+47.6%) | $15.44 M(+126.5%) |
| Sep 2022 | - | $6.82 M(+0.2%) |
| Jun 2022 | - | $6.81 M(-12.3%) |
| Mar 2022 | - | $7.76 M |
| Dec 2021 | $24.96 M(+36.4%) | - |
| Dec 2020 | $18.30 M | - |
FAQ
- What is ARS Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual operating expenses year-on-year change?
- What is ARS Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly operating expenses year-on-year change?
What is ARS Pharmaceuticals annual total operating expenses?
The current annual operating expenses of SPRY is $67.55 M
What is the all time high annual operating expenses for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual total operating expenses is $67.55 M
What is ARS Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, SPRY annual total operating expenses has changed by +$30.72 M (+83.40%)
What is ARS Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of SPRY is $23.70 M
What is the all time high quarterly operating expenses for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly total operating expenses is $23.70 M
What is ARS Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, SPRY quarterly total operating expenses has changed by +$7.86 M (+49.65%)